European Pharmaceutical Review

NOVEMBER 11, 2022

The paper suggested low bioavailability after topical ophthalmic administration is evidence of the need for more effective molecules, as well as formulations that target sites more precisely. A key challenge discussed is active pharmaceutical ingredient (API) impurity profiling in finished dosage forms. The paper by Asendrych-Wicik et.

Pharmaceutical 95

Pharmaceutical Safety Medicine 95

European Pharmaceutical Review

AUGUST 3, 2022

The ideas and proposals put forward on this topic during the recent EDQM Symposium on Nanomedicines will be taken into account during the process, as will the experience gained with these vaccines during the COVID-19 pandemic, in which mRNA vaccines garnered regulatory approval for the first time.

Manufacturing 98

Manufacturing Government Safety Medicine 98

Map My Customers

JULY 25, 2022

billion in annual B2B purchases found that those who are most successful in sales make strong personal connections at double the rate of second place finishers. SWOT Analysis for Territory Planning Spend any time researching this topic, and SWOT is an acronym you’re likely to come across.

Sales territory 79

Sales territory Sales Competition Sales process 79

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Another major topic covered by the experts was technological advances. Miriam Guest, Principal Microbiologist at AstraZeneca.

Pharmaceutical 128

Pharmaceutical Food and Drug Administration Manufacturing FDA 128

European Pharmaceutical Review

FEBRUARY 23, 2023

Despite this overlap, this article addresses the main challenges for industry and firms, and those for pharmaceutical microbiologists, separately, focusing on some of the difficult and often overlooked hurdles relating to quality assurance (QA) and quality control (QC) of licensed and marketed pharmaceutical drug products.

Pharmaceutical 101

Pharmaceutical Management Manufacturing Recruitment 101

Pharmaceutical Technology

MARCH 29, 2023

While there is no cure for this particular indication, symptoms may be alleviated with treatments such as antihistamines and topically administered lidocaine. Although the company has recently finished a EUR20 million Series B, a potential Series C is planned for next year, says the CEO. Evaluate the effects of COVID-19 on the sector.

Recruitment 52

Recruitment Patients Prospecting Competition 52